跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
HYDRALAZINE - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
HYDRALAZINE
Authorized
STANDARD
HYDRALAZINE
sanis health inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
da5a730ca90e5f70
Company
sanis health inc
Type
Standard
Approval Details
Approval Id
da5a730ca90e5f70
Drug Approval Canada Name
HYDRALAZINE
Product Name
HYDRALAZINE
Status
Marketed
Status Date
2024-02-29
Original Market Date
2024-02-29
Din
02539802
Drug Class
Human
Dosage Form
Tablet
Route Of Administration
Oral
Schedule
Prescription
Ahfs
24:08.20
Atc Original
C02DB02 HYDRALAZINE
Atc Name
c 02 db 02
Aig Number
0107444003
Company Name
sanis health inc
Company Address
1 Presidents Choice Circle, Brampton, Ontario, Canada, L6Y 5S5
Active Ingredients
HYDRALAZINE HYDROCHLORIDE
10 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
da5a730ca90e5f70
Type
Standard
Back to Health Canada Approvals